EUROPE MULTIPLEX ASSAY MARKET 2021-2028

Lifesciences | Diagnostic & Biotechnology

EUROPE MULTIPLEX ASSAY MARKET 2021-2028

Market by Product and Service, Type, Application, Technology, Industry Verticals, and Country | Forecast 2021-2028

Request For Customization

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

As per Triton’s report, the multiplex assay market in Europe is assessed to obtain a CAGR of 8.30% in terms of revenue during the forecasted phase of 2021-2028.  


Report scope can be customized per your requirements. Request For Customization

The countries examined in this market include:

•        The United Kingdom

•        Spain

•        Germany

•        Italy

•        France

•        Russia

•        Rest of Europe

Europe’s multiplex assay market is likely to grow at a steady pace over the forecast period, owing to the rise of government focus towards technological advancements in medical devices, increase in healthcare expenditure, and well-developed healthcare systems. Along with this, the high prevalence of chronic diseases, coupled with the increase in the geriatric population, is estimated to contribute to the growth of the multiple assay market in the next few years.

Furthermore, the studied market is mainly driven by the rise in the pharmaceutical industry and clinical trials across Germany. In this regard, multiplex assay technology is anticipated to help pharma companies lower clinical trial costs by reducing approval time. Besides, the country is among the significant destinations for pharmaceutical research and development. Thus, the extensive research activities in the pharma industry are likely to drive the use of digital PCR, opening new avenues for the multiplex assay market during the assessed period. 

Furthermore, governmental support to domestic and international organizations to set up new manufacturing centers to expand R&D activities is likely to fuel the growth of the German multiplex assay market over the forecast period. 

Randox Laboratories Ltd is a clinical diagnostic company that offers clinical diagnostic solutions to laboratories. Its product line includes biochip analyzers, clinical chemistry analyzers, biochip immunoassays, and diagnostic reagents. In addition, it provides diagnostic, prognostic, and predictive solutions for cardiovascular diseases, cancer, and others. Randox has operations across various regions, with headquarters in the United Kingdom. 

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. EUROPE MULTIPLEX ASSAY MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON MULTIPLEX ASSAY MARKET

2.2. KEY INSIGHTS

2.3. PORTER’S FIVE FORCES MODEL

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTE PRODUCTS

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. COMPETITIVE RIVALRY

2.4. KEY BUYING OUTLOOK

2.5. MARKET ATTRACTIVENESS INDEX

2.6. VENDOR SCORECARD

2.7. KEY MARKET STRATEGIES

2.7.1. CONTRACTS AND PARTNERSHIPS

2.7.2. BUSINESS EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES

2.7.3. ACQUISITIONS & MERGERS

2.7.4. NEW PRODUCT LAUNCHES & DEVELOPMENTS

2.8. KEY DRIVERS

2.8.1.   ADOPTION OF PERSONALIZED MEDICINES

2.8.2.   HIGH ADOPTION OF MULTIPLEX ASSAYS OVER TRADITIONAL METHODS

2.9. KEY RESTRAINTS

2.9.1. DEARTH OF SKILLED PROFESSIONALS

2.9.2. LEGAL TRENDS RELATED TO ENVIRONMENTAL SAFETY

2.10. KEY OPPORTUNITIES

2.10.1. FUNDING FOR R&D ACTIVITIES BY VARIOUS GOVERNMENT AGENCIES AND COMPANIES

3. EUROPE MULTIPLEX ASSAY MARKET - BY PRODUCT AND SERVICE

3.1. REAGENTS AND CONSUMABLES

3.2. INSTRUMENTS AND ACCESSORIES

3.3. SOFTWARE AND SERVICES

4. EUROPE MULTIPLEX ASSAY MARKET - BY TYPE

4.1. PROTEIN-BASED MULTIPLEX ASSAY

4.2. NUCLEIC ACID-BASED MULTIPLEX ASSAY

4.3. OTHER MULTIPLEX ASSAYS

5. EUROPE MULTIPLEX ASSAY MARKET - BY APPLICATION

5.1. RESEARCH AND DEVELOPMENT

5.2. CLINICAL DIAGNOSTICS

5.3. COMPANION DIAGNOSTICS

6. EUROPE MULTIPLEX ASSAY MARKET - BY TECHNOLOGY

6.1. MULTIPLEX PROTEIN MICROARRAY

6.2. MULTIPLEX PCR

6.3. OTHER TECHNOLOGIES

7. EUROPE MULTIPLEX ASSAY MARKET - BY INDUSTRY VERTICALS

7.1. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

7.2. RESEARCH INSTITUTES

7.3. CLINICAL LABORATORIES

7.4. HOSPITALS

8. EUROPE MULTIPLEX ASSAY MARKET – COUNTRY OUTLOOK

8.1. COUNTRY ANALYSIS

8.1.1. GERMANY

8.1.2. FRANCE

8.1.3. UNITED KINGDOM

8.1.4. ITALY

8.1.5. RUSSIA

8.1.6. SPAIN

8.1.7. REST OF EUROPE

9. COMPETITIVE LANDSCAPE

9.1. ABCAM

9.2. AGILENT TECHNOLOGIES INC

9.3. BECTON DICKINSON AND COMPANY

9.4. BIO RAD LABORATORIES INC

9.5. BIO TECHNE CORPORATION

9.6. F HOFFMANN LA ROCHE

9.7. ILLUMINA INC

9.8. LUMINEX CORPORATION

9.9. MERCK MILLIPORE

9.10. MESO SCALE DIAGNOSTICS LLC

9.11. OLINK PROTEOMICS AB

9.12. QIAGEN NV

9.13. RANDOX LABORATORIES LTD

9.14. SEEGENE INC

9.15. SIEMENS HEALTHINEERS AG

9.16. THERMO FISHER SCIENTIFIC INC

10. RESEARCH METHODOLOGY & SCOPE

10.1. RESEARCH SCOPE & DELIVERABLES

10.1.1. OBJECTIVES OF STUDY

10.1.2. SCOPE OF STUDY

10.2. SOURCES OF DATA

10.2.1. PRIMARY DATA SOURCES

10.2.2. SECONDARY DATA SOURCES

10.3. RESEARCH METHODOLOGY

10.3.1. EVALUATION OF PROPOSED MARKET

10.3.2. IDENTIFICATION OF DATA SOURCES

10.3.3. ASSESSMENT OF MARKET DETERMINANTS

10.3.4. DATA COLLECTION

10.3.5. DATA VALIDATION & ANALYSIS

List of Tables

TABLE 1:       EUROPE MULTIPLEX ASSAY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

TABLE 2:       VENDOR SCORECARD

TABLE 3:       CONTRACTS AND PARTNERSHIPS

TABLE 4:       LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES

TABLE 5:       ACQUISITIONS & MERGERS

TABLE 6:       LIST OF NEW PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 7:       EUROPE MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, 2021-2028 (IN $ MILLION)

TABLE 8:       EUROPE MULTIPLEX ASSAY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)

TABLE 9:       EUROPE MULTIPLEX ASSAY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)

TABLE 10:     EUROPE MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)

TABLE 11:     EUROPE MULTIPLEX ASSAY MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)

TABLE 12:     EUROPE MULTIPLEX ASSAY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1:     EUROPE MULTIPLEX ASSAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 2:     EUROPE MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, 2020 & 2028 (IN %)

FIGURE 3:     EUROPE MULTIPLEX ASSAY MARKET, BY REAGENTS AND CONSUMABLES, 2021-2028 (IN $ MILLION)

FIGURE 4:     EUROPE MULTIPLEX ASSAY MARKET, BY INSTRUMENTS AND ACCESSORIES, 2021-2028 (IN $ MILLION)

FIGURE 5:     EUROPE MULTIPLEX ASSAY MARKET, BY SOFTWARE AND SERVICES, 2021-2028 (IN $ MILLION)

FIGURE 6:     EUROPE MULTIPLEX ASSAY MARKET, BY TYPE, 2020 & 2028 (IN %)

FIGURE 7:     EUROPE MULTIPLEX ASSAY MARKET, BY PROTEIN-BASED MULTIPLEX ASSAY, 2021-2028 (IN $ MILLION)

FIGURE 8:     EUROPE MULTIPLEX ASSAY MARKET, BY NUCLEIC ACID-BASED MULTIPLEX ASSAY, 2021-2028 (IN $ MILLION)

FIGURE 9:     EUROPE MULTIPLEX ASSAY MARKET, BY OTHER MULTIPLEX ASSAYS, 2021-2028 (IN $ MILLION)

FIGURE 10:  EUROPE MULTIPLEX ASSAY MARKET, BY APPLICATION, 2020 & 2028 (IN %)

FIGURE 11:  EUROPE MULTIPLEX ASSAY MARKET, BY RESEARCH AND DEVELOPMENT, 2021-2028 (IN $ MILLION)

FIGURE 12:  EUROPE MULTIPLEX ASSAY MARKET, BY CLINICAL DIAGNOSTICS, 2021-2028 (IN $ MILLION)

FIGURE 13:  EUROPE MULTIPLEX ASSAY MARKET, BY COMPANION DIAGNOSTICS, 2021-2028 (IN $ MILLION)

FIGURE 14:  EUROPE MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2020 & 2028 (IN %)

FIGURE 15:  EUROPE MULTIPLEX ASSAY MARKET, BY MULTIPLEX PROTEIN MICROARRAY, 2021-2028 (IN $ MILLION)

FIGURE 16:  EUROPE MULTIPLEX ASSAY MARKET, BY MULTIPLEX PCR, 2021-2028 (IN $ MILLION)

FIGURE 17:  ADVANTAGES OF IMMUNOHISTOCHEMISTRY (IHC)

FIGURE 18:  EUROPE MULTIPLEX ASSAY MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)

FIGURE 19:  EUROPE MULTIPLEX ASSAY MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)

FIGURE 20:  EUROPE MULTIPLEX ASSAY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)

FIGURE 21:  EUROPE MULTIPLEX ASSAY MARKET, BY RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)

FIGURE 22:  EUROPE MULTIPLEX ASSAY MARKET, BY CLINICAL LABORATORIES, 2021-2028 (IN $ MILLION)

FIGURE 23:  EUROPE MULTIPLEX ASSAY MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)

FIGURE 24:  GERMANY MULTIPLEX ASSAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 25:  FRANCE MULTIPLEX ASSAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 26:  UNITED KINGDOM MULTIPLEX ASSAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 27:  ITALY MULTIPLEX ASSAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 28:  RUSSIA MULTIPLEX ASSAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 29:  SPAIN MULTIPLEX ASSAY MARKET 2021-2028 (IN $ MILLION)

FIGURE 30:  REST OF EUROPE MULTIPLEX ASSAY MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$1,500.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$2,200.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying